Brief: Ekso Bionics Reports First Quarter 2022 Results
28/04/2022 21:51
April 28 (Reuters) - Ekso Bionics Holdings Inc EKSO.O :
* EKSO BIONICS REPORTS FIRST QUARTER 2022 RESULTS
* Q1 LOSS PER SHARE $0.36
* Q1 REVENUE $2.6 MILLION
* CASH POSITION OF $36.2 MILLION AT MARCH 31, 2022
Source text for Eikon: ID:nGNX26CMls
Further company coverage: EKSO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Chronoscale
See all newsBrief: Chronoscale To Divest Ekso Bionics And Focus On Cloud Business
Brief: Applied Digital Completes Separation Of Cloud Business, Establishing Chronoscale As Independent Public Company
Brief: Ekso Bionics Holdings On Feb 15, Enters Agreement With Apld Intermediate
Applied Digital jumps after Q2 revenue beats on AI data center demand
Applied Digital beats quarterly revenue estimates on AI data center demand, shares jump